Compare TOUR & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOUR | MDAI |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.6M | 50.5M |
| IPO Year | 2014 | 2021 |
| Metric | TOUR | MDAI |
|---|---|---|
| Price | $5.04 | $1.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 6.8K | ★ 142.2K |
| Earning Date | 06-11-2026 | 05-12-2026 |
| Dividend Yield | ★ 17.12% | N/A |
| EPS Growth | N/A | ★ 65.88 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,650,000.00 |
| Revenue This Year | $17.30 | N/A |
| Revenue Next Year | $14.00 | $23.50 |
| P/E Ratio | $87.34 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.56 | $1.18 |
| 52 Week High | $7.79 | $2.97 |
| Indicator | TOUR | MDAI |
|---|---|---|
| Relative Strength Index (RSI) | 52.03 | 42.94 |
| Support Level | $4.93 | $1.49 |
| Resistance Level | $5.32 | $1.77 |
| Average True Range (ATR) | 0.12 | 0.06 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 49.20 | 8.62 |
Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. The company offers a large selection of packaged tours, including organized tours and self-guided tours, and travel-related services for leisure travellers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.